“They had to do what I said because I was in uniform and had a gun and a badge,” Couch said in a statement read to the jury. “Because I was in control.”
Though critically-ill people are allowed by the FDA to take non-approved medications, Chimerix, a small drug company in North Carolina, is not giving a life-saving drug to a boy laying in a Tennessee hospital.
March 14, 2014 update: Since this article was published, Chimerix has provided Brincidofovir to Josh Hardy as the first patient in its new open-label study in patients with adenovirus infections.
As seven-year-old Josh Hardy lies in a bed in St. Jude’s